InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
0
T+90 hit rate
50%
T+90 mean return
+3.4%
Across 4 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the complete record of transactions filed by WHEELER CRAIG A, Director. Officer active across 4 companies, notably Apellis Pharmaceuticals, Inc.. Cumulatively, 9 disclosures have been published. Activity tracked since 10 June 2021. The latest transaction was disclosed on 17 April 2025 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Declarations9 total
24,444 sharesCommon StockSEC:0001193125-26-224585
24,444 sharesCommon StockSEC:0001193125-26-224585:0
16,483 shares0Common StockSEC:0001127602-25-012384:0
11,847 shares0Common StockSEC:0000950170-24-071009:0
8,584 shares0Common StockSEC:0001209191-23-036412:0
12,671 shares0Common StockSEC:0001209191-22-035857:0
10,115 shares0Common StockSEC:0001209191-21-040379
10,115 shares0Common StockSEC:0001209191-21-040379:0
63,000 sharesCommon StockSEC:0001179110-16-018968:0
9 of 9 declarations
About WHEELER CRAIG A
Craig A. Wheeler is a Director at Apellis Pharmaceuticals, Inc. and Amicus Therapeutics, Inc. He brings expertise in management and business strategy to the boards. His role is essential in guiding strategic decisions and ensuring the sustainable growth of the companies.
